Asahi Kasei To Acquire Calliditas Therapeutics For SEK 11.8 Billion

Asahi Kasei Corp. declares that Asahi Kasei will acquire the shares of the drug organization Calliditas to make Calliditas an entirely owned subsidiary of Asahi Kasei through a deliberate delicate proposal for Calliditas. The Tender Offer will...

US FDA Nods Amgen's Biosimilar to AstraZeneca's Blood Disorder Treatment

The U.S. Food and Drug Administration sanctioned Amgen's Bkemv, the first biosimilar to AstraZeneca's intriguing blood problem treatment Soliris. Amgen's medication will be advertised under the name Bkemv. Biosimilars are close duplicates of...

AstraZeneca Pharma Net Profit Rises To Rs. 39.5 crore in Q4FY24

AstraZeneca Pharma India Ltd's net profit for the quarter ended March 31, 2024 has doubled to Rs. 39.48 crore, up from Rs. 17.27 crore in the same time last fiscal year. Total income increased 34% to Rs. 391.86 crore during the quarter, compared...

Breakthrough Achieved by Chinese Scientists in Developing Diabetes Cure

In a huge clinical achievement, Chinese researchers have effectively cured a patient's diabetes utilizing a groundbreaking cell therapy. This spearheading treatment was created by a group from Shanghai Changzheng Emergency clinic, the Centre for...

Oncocross and JW Pharma Expand Partnership To Develop Innovative New Drugs

Oncocross, a pharmaceutical firm, declared on May 22nd that it has consented to a joint exploration arrangement with JW Pharmaceutical to foster new medications in view of the AI platform. Under this agreement, the two organizations will join...

EMA Confirms Henlius & Organon’s Marketing Authorization App For Prolia

Shanghai Henlius Biotech, Inc., a global biopharmaceutical firm, and Organon reported that the European Medicines Agency (EMA) has approved the marketing authorization applications (MAAs) for HLX14, an experimental Prolia and Xgeva (denosumab)...

Novotech Signs MoU with New Zealand Clinical Research

Novotech Pty Ltd., the worldwide clinical contract research organization (CRO) that accomplices with biotech organizations to speed up the improvement of cutting edge and novel therapeutics at each stage, has marked a MoU with New Zealand Clinical...

West Pharmaceutical Services Expands Capabilities in Asia

West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug administration, today announced it has relocated to a new office facility in Seoul and expanded its warehouse capacity. This is part of West's...

Eli Lilly Funds Another USD 5.3 Billion in Indiana Unit

Eli Lilly, a pharmaceutical company, has declared it is funding one more $5.3 billion in an manufacturing plant in Lebanon, Indiana, to support the assembling of its exceptionally famous weight reduction drug Zepbound, diabetes treatment Mounjaro...

US FDA Awards Fast Track Designation To Theriva Biologic's VCN-01

The US Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to lead clinical candidate VCN-01 in combination with gemcitabine and nab-paclitaxel to improve progression-free survival and overall survival in patients with...

© 2025 India Pharma Outlook. All Rights Reserved.